| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |